FDA Approved: VYLOY — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved the original Biologics License Application for VYLOY (zolbetuximab) from Astellas Pharma US, enabling its use for a gastric/gastroesophageal juncti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• VYLOY (ZOLBETUXIMAB)

Snippet

ORIG AP for VYLOY (ZOLBETUXIMAB)